Informations générales (source: ClinicalTrials.gov)

NCT03197792 Statut inconnu
Perioperative Transesophageal Portal Vein Pulsatility as a Predictor of Persistent Organ Dysfunction Plus Death 7 Days After Pulmonary Endarterectomy (PVP-ETO-CPC)
Interventional
  • Défaillance cardiaque
  • Hypertension artérielle
  • Hypertension pulmonaire
  • Complications postopératoires
  • Embolie pulmonaire
  • Thromboembolie
N/A
Centre Chirurgical Marie Lannelongue (Voir sur ClinicalTrials)
mai 2017
mai 2019
29 juin 2024
The investigators aim to evaluate the utility of portal vein pulsatility as a predictor of the composite outcome of persistent organ dysfunction plus death in patients undergoing elective or urgent pulmonary endarterectomy for thromboembolic pulmonary hypertension. The investigators' hypothesis is that the portal vein pulsatility fraction, measured using transesophageal echocardiography immediately after weaning of cardiopulmonary bypass, is proportional to the risk of developing subsequent end-organ dysfunction in the postoperative setting.
 Voir le détail

Etablissements

Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
HOPITAL MARIE LANNELONGUE TRAORE AMINATA, CEC En recrutement IDF Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- 18 years or older

- Elective or urgent pulmonary endarterectomy


- absolute or relative contraindication to the use of transesophageal
echocardiography,

- hepatic cirrhosis,

- portal vein thrombosis,

- concomitant coronary artery bypass grafting,

- patient refusal or unable to give informed consent